Showing results (281-290 of 315) with videos related to

Sort By:
Pageof 32
Neurogastroenterology and Motility|August 11, 2021
Neurotensin secretion after Roux-en-Y gastric bypass, sleeve gastrectomy, and truncal vagotomy with pyloroplastyMaria S Svane, Caroline C Øhrstrøm, Astrid Plamboeck, et al.
Diabetes, Obesity & Metabolism|June 5, 2020
No effects of a 6-week intervention with a glucagon-like peptide-1 receptor agonist on pancreatic volume and oedema in obese men without diabetesMaria S Svane, Helle H Johannesen, Christoffer Martinussen, et al.
Ebiomedicine|June 21, 2016
Oxyntomodulin Identified as a Marker of Type 2 Diabetes and Gastric Bypass Surgery by Mass-spectrometry Based Profiling of Human PlasmaNicolai J Wewer Albrechtsen, Daniel Hornburg, Reidar Albrechtsen, et al.
International Journal of Obesity (2005)|February 5, 2020
Secretin release after Roux-en-Y gastric bypass reveals a population of glucose-sensitive S cells in distal small intestineIda M Modvig, Daniel B Andersen, Kaare V Grunddal, et al.
International Journal of Obesity (2005)|August 31, 2023
Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intakeKirstine Nyvold Bojsen-Møller, Maria Saur Svane, Christoffer Martinussen, et al.
Diabetes|March 6, 2026
Effects of Pancreatic Resection on Liver Fat Content and Amino Acid, Lipid, and Glucose Metabolism: A Prospective 1-Year Follow-up StudyMagnus F G Grøndahl, Iben Rix, Lars F Garvey, et al.
Iscience|January 8, 2026
Exercise maintains LEAP2 levels after weight loss in females with obesityJoachim Holt, Stephanie K Holm, Rasmus M Sandsdal, et al.
Pharmacological Research|January 7, 2022
GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatmentMaria Buur Nordskov Gabe, Kirsa Skov-Jeppesen, Lærke Smidt Gasbjerg, et al.
The Journal of Clinical Endocrinology and Metabolism|February 25, 2022
Hyperglucagonemia in Pediatric Adiposity Associates With Cardiometabolic Risk Factors but Not HyperglycemiaSara E Stinson, Anna E Jonsson, Ierai Fernández de Retana Alzola, et al.
The Journal of Clinical Endocrinology and Metabolism|May 26, 2023
Rare Heterozygous Loss-of-Function Variants in the Human GLP-1 Receptor Are Not Associated With Cardiometabolic PhenotypesJosefine U Melchiorsen, Kimmie V Sørensen, Jette Bork-Jensen, et al.
Pageof 32